investorscraft@gmail.com

Intrinsic Value of HCA Healthcare, Inc. (HCA)

Previous Close$376.58
Intrinsic Value
Upside potential
Previous Close
$376.58

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

HCA Healthcare, Inc. operates as a leading for-profit healthcare provider in the U.S., delivering a comprehensive range of medical services through its network of hospitals, outpatient centers, and physician clinics. The company generates revenue primarily through patient care services, including inpatient and outpatient treatments, emergency care, and surgical procedures. Its vertically integrated model allows for cost efficiencies and scale advantages, positioning HCA as a dominant player in high-growth urban and suburban markets. HCA differentiates itself through advanced clinical capabilities, strategic partnerships with physicians, and investments in technology to enhance patient outcomes. The company’s market leadership is reinforced by its focus on high-acuity services, which command premium pricing and drive margin expansion. Operating in a highly regulated and competitive industry, HCA leverages its scale to negotiate favorable payer contracts while maintaining a reputation for quality care. Its diversified geographic footprint mitigates regional risks and supports steady demand, underpinned by demographic trends favoring healthcare utilization.

Revenue Profitability And Efficiency

HCA reported $70.6 billion in revenue for FY 2024, reflecting its ability to monetize high-acuity services and manage costs effectively. Net income stood at $5.8 billion, with diluted EPS of $22, demonstrating robust profitability. Operating cash flow of $10.5 billion underscores strong cash generation, though capital expenditures of $4.9 billion indicate significant reinvestment in facilities and technology to sustain growth.

Earnings Power And Capital Efficiency

The company’s earnings power is evident in its consistent margin performance, driven by operational discipline and pricing leverage. HCA’s capital efficiency is supported by its ability to generate high returns on invested capital, though its debt-heavy capital structure necessitates careful liquidity management. The balance between growth investments and shareholder returns remains a key focus.

Balance Sheet And Financial Health

HCA’s balance sheet shows $1.9 billion in cash and equivalents against $45.2 billion in total debt, reflecting a leveraged but manageable position. The company’s strong cash flow generation provides ample coverage for debt servicing and strategic investments. Financial health is further supported by its ability to access capital markets at favorable terms.

Growth Trends And Dividend Policy

HCA has demonstrated steady growth through organic volume increases and selective acquisitions. The company’s dividend policy, with a $2.67 per share payout, signals confidence in sustained cash flow generation. Future growth is expected to be driven by demographic tailwinds and operational efficiencies, though regulatory pressures remain a monitorable risk.

Valuation And Market Expectations

Market expectations for HCA reflect its leadership position and growth prospects, with valuations factoring in its ability to maintain margins amid cost pressures. The stock’s performance is closely tied to healthcare utilization trends and reimbursement dynamics, with investors pricing in moderate earnings growth.

Strategic Advantages And Outlook

HCA’s strategic advantages include its scale, clinical expertise, and geographic diversification. The outlook remains positive, supported by aging demographics and increasing healthcare demand. However, regulatory changes and labor cost inflation could pose challenges. The company’s focus on technology and efficiency initiatives positions it well for long-term success.

Sources

10-K, investor presentations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount